Oligodendrocytes: Potential of Discovering New Treatment Targets (Q64062621)

1

0 references

Valéria de Almeida

2

0 references

Juliana S Cassoli

3

0 references

Daniel Martins-de-Souza

Frontiers in Pharmacology

4

0 references

language of work or name

English

0 references

publication date

2019

0 references

published in

0 references

volume

10

0 references

page(s)

186

0 references

copyright license

Creative Commons Attribution 4.0 International

start time

5 March 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Implication of ATP receptors in brain functions

1 reference

12 December 2020

The Glutamatergic Dysfunction Hypothesis for Schizophrenia

1 reference

12 December 2020

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

12 December 2020

A history of antipsychotic drug development

1 reference

12 December 2020

Schizophrenia: a purinergic hypothesis

1 reference

12 December 2020

14-3-3 proteins: structure, function, and regulation

1 reference

12 December 2020

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

1 reference

12 December 2020

Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia.

1 reference

12 December 2020

Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats

1 reference

12 December 2020

Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia

1 reference

12 December 2020

Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia

1 reference

12 December 2020

Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: Morphology and oligodendrocyte-specific gene expression

1 reference

12 December 2020

Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium.

1 reference

12 December 2020

Altered expression of 14-3-3 genes in the prefrontal cortex of subjects with schizophrenia

1 reference

12 December 2020

Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts

1 reference

12 December 2020

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

12 December 2020

Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease

1 reference

12 December 2020

Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia

1 reference

12 December 2020

Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia

1 reference

12 December 2020

Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes

1 reference

12 December 2020

Nucleotide-sugar transporters: structure, function and roles in vivo

1 reference

12 December 2020

eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia?

1 reference

12 December 2020

The effect of MK-801 on mTOR/p70S6K and translation-related proteins in rat frontal cortex

1 reference

12 December 2020

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

1 reference

12 December 2020

Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures

1 reference

12 December 2020

Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation

1 reference

12 December 2020

Identification of ROS using oxidized DCFDA and flow-cytometry.

1 reference

12 December 2020

Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood

1 reference

12 December 2020

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism

1 reference

12 December 2020

Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia

1 reference

12 December 2020

Proteome analyses of cultured astrocytes treated with MK-801 and clozapine: similarities with schizophrenia.

1 reference

12 December 2020

Dysfunctional gene splicing as a potential contributor to neuropsychiatric disorders

1 reference

12 December 2020

Altering the expression balance of hnRNP C1 and C2 changes the expression of myelination-related genes

1 reference

12 December 2020

Neuroprotective effects of alpha lipoic Acid on haloperidol-induced oxidative stress in the rat brain

1 reference

12 December 2020

Using ion purity scores for enhancing quantitative accuracy and precision in complex proteomics samples

1 reference

12 December 2020

Adenosine hypothesis in schizophrenia and bipolar disorder: a systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators

1 reference

12 December 2020

Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity.

1 reference

12 December 2020

Antipsychotics activate mTORC1-dependent translation to enhance neuronal morphological complexity

1 reference

12 December 2020

A day in the life of the spliceosome

1 reference

12 December 2020

White matter injuries induced by MK-801 in a mouse model of schizophrenia based on NMDA antagonism

1 reference

12 December 2020

Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes.

1 reference

12 December 2020

Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: potential roles in GABAergic interneuron pathology

1 reference

12 December 2020

Dose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose Method

1 reference

12 December 2020

Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains

1 reference

12 December 2020

The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia.

1 reference

12 December 2020

Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes

1 reference

12 December 2020

Dysregulated 14-3-3 Family in Peripheral Blood Leukocytes of Patients with Schizophrenia

1 reference

12 December 2020

Synapse pathology and translational applications for schizophrenia

1 reference

12 December 2020

Cuprizone Intoxication Induces Cell Intrinsic Alterations in Oligodendrocyte Metabolism Independent of Copper Chelation.

1 reference

12 December 2020

MK-801-Treated Oligodendrocytes as a Cellular Model to Study Schizophrenia

1 reference

12 December 2020

Antioxidant effects of rice bran oil mitigate repeated haloperidol-induced tardive dyskinesia in male rats

1 reference

12 December 2020

Neuregulin 3 and its roles in schizophrenia risk and presentation.

1 reference

12 December 2020

Ion mobility-enhanced data-independent acquisitions enable a deep proteomic landscape of oligodendrocytes.

1 reference

12 December 2020

The Nuclear Proteome of White and Gray Matter from Schizophrenia Postmortem Brains

1 reference

12 December 2020